K. J. Dornfeld

Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit

A. Rehemtulla, B. Moffat, D. Hamstra, 2006, Gene Therapy.

The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model

Z Symon, A. Rehemtulla, Z. Symon, 2002, Gene Therapy.

Ex vivo gene therapy for skeletal regeneration in cranial defects compromised by postoperative radiotherapy.

R. Rutherford, T. Teknos, P. Krebsbach, 2003, Human gene therapy.